Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Heron Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 200 | 186 | −14 |
| Shares | 117.6M | 108.5M | −9.10M (−7.7%) |
| Value | $1.07B | $620.5M | −$453.1M (−42.2%) |
New holders (22)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 125,932 | $720.0K | 0.00% |
| Qube Research & Technologies Ltd | 77,081 | $441.0K | 0.00% |
| Zweig-DiMenna Associates LLC | 51,500 | $295.0K | 0.04% |
| Man Group plc | 43,000 | $246.0K | 0.00% |
| Jump Financial, LLC | 29,161 | $167.0K | 0.01% |
| Prelude Capital Management, LLC | 20,600 | $118.0K | 0.01% |
| XTX Topco Ltd | 20,436 | $117.0K | 0.05% |
| HSBC Holdings PLC | 19,698 | $112.0K | 0.00% |
| Quantbot Technologies LP | 18,238 | $104.0K | 0.01% |
| Janus Henderson Group PLC | 17,730 | $102.0K | 0.00% |
| Amalgamated Financial Corp. | 15,043 | $86.0K | 0.00% |
| Engineers Gate Manager LP | 12,838 | $73.0K | 0.00% |
| Bridgefront Capital, LLC | 10,493 | $60.0K | 0.07% |
| Point72 Hong Kong Ltd | 8,355 | $48.0K | 0.00% |
| Bourgeon Capital Management LLC | 3,000 | $17.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 745 | $4.00K | 0.00% |
| Signaturefd, LLC | 353 | $2.00K | 0.00% |
| AdvisorNet Financial, Inc | 110 | $1.00K | 0.00% |
| First Horizon Advisors, Inc. | 56 | $0 | 0.00% |
| Ellevest, Inc. | 7 | $0 | 0.00% |
| GPS Wealth Strategies Group, LLC | 72 | $0 | 0.00% |
| Federated Hermes, Inc. | 2 | – | – |
Sold out (36)
Institutions that held Heron Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.